Although the precise role of MS4A4A, MS4A4E, and MS4A6E in Alzheimer’s disease is still under investigation, current evidence suggests that genetic variations in these proteins may affect immune function and microglial activity in the brain—key elements in the development of Alzheimer’s [79]. This evidence concerns the gene MS4A4A and early-onset autosomal dominant Alzheimer disease.